Cerus (CERS) Total Current Liabilities (2010 - 2026)
Cerus' (CERS) quarterly Total Current Liabilities came in at $107.4 million in Q1 2026, up 54.09% year-on-year from $69.7 million in Q1 2025, and up 6.53% quarter-over-quarter from $100.8 million in Q4 2025.
Cerus (CERS) Total Current Liabilities (2010 - 2026) Analysis & Trends
Cerus has disclosed Total Current Liabilities across 17 years of filings, most recently posting $107.4 million for Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $107.4 million, up 54.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $107.4 million (up 54.09% YoY), and the FY2025 annual result was $100.8 million, up 58.47% from the prior year.
- Total Current Liabilities came in at $107.4 million for Q1 2026 at Cerus, up from $100.8 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $117.1 million in Q4 2022 to a low of $53.9 million in Q2 2024.
- The 5-year median for Total Current Liabilities is $77.6 million (2023), against an average of $78.7 million.
- Across the five-year window, Total Current Liabilities slumped 42.32% in 2023 and soared 62.73% in 2025, its largest moves.
- Cerus' Total Current Liabilities stood at $117.1 million in 2022, then plunged by 42.32% to $67.5 million in 2023, then dropped by 5.8% to $63.6 million in 2024, then jumped by 58.47% to $100.8 million in 2025, then climbed by 6.53% to $107.4 million in 2026.
- The last three Total Current Liabilities figures came in at $107.4 million (Q1 2026), $100.8 million (Q4 2025), and $88.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 9.50 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 1.41 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 8.53 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.70 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 2.22 Bn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 1.15 Bn |
| 10 | Cerus | 496.03 Mn | 416.34 Mn | 27.89 Mn | 107.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 107.38 Mn |
| Dec 31, 2025 | 100.80 Mn |
| Sep 30, 2025 | 88.43 Mn |
| Jun 30, 2025 | 84.36 Mn |
| Mar 31, 2025 | 69.69 Mn |
| Dec 31, 2024 | 63.61 Mn |
| Sep 30, 2024 | 54.35 Mn |
| Jun 30, 2024 | 53.88 Mn |
| Mar 31, 2024 | 57.25 Mn |
| Dec 31, 2023 | 67.52 Mn |
| Sep 30, 2023 | 80.12 Mn |
| Jun 30, 2023 | 75.08 Mn |
| Mar 31, 2023 | 77.57 Mn |
| Dec 31, 2022 | 117.06 Mn |
| Sep 30, 2022 | 95.02 Mn |
| Jun 30, 2022 | 79.28 Mn |
| Mar 31, 2022 | 66.66 Mn |
| Dec 31, 2021 | 78.56 Mn |
| Sep 30, 2021 | 64.72 Mn |
| Jun 30, 2021 | 65.82 Mn |